Lars Østergaard

16.1k total citations · 3 hit papers
285 papers, 9.6k citations indexed

About

Lars Østergaard is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Lars Østergaard has authored 285 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Epidemiology, 96 papers in Infectious Diseases and 68 papers in Microbiology. Recurrent topics in Lars Østergaard's work include HIV Research and Treatment (57 papers), Reproductive tract infections research (45 papers) and HIV/AIDS Research and Interventions (42 papers). Lars Østergaard is often cited by papers focused on HIV Research and Treatment (57 papers), Reproductive tract infections research (45 papers) and HIV/AIDS Research and Interventions (42 papers). Lars Østergaard collaborates with scholars based in Denmark, United States and Guinea-Bissau. Lars Østergaard's co-authors include Ole S. Søgaard, Martin Tolstrup, Jens Kjølseth Møller, Berit Andersen, Frede Olesen, Thomas A. Rasmussen, Søren R. Paludan, Trine H. Mogensen, Poul Thorsen and Hjördís Ósk Atladóttir and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Lars Østergaard

280 papers receiving 9.4k citations

Hit Papers

Maternal Infection Requiring Hospitalization During Pregn... 2010 2026 2015 2020 2010 2014 2015 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders
    2010 688 citations Lars Østergaard et al. profile →
  2. Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
    2014 472 citations Martin Tolstrup, Rikke Olesen et al. profile →
  3. The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
    2015 379 citations Ole S. Søgaard, Steffen Leth et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Østergaard Denmark 51 3.1k 2.8k 2.3k 2.2k 1.8k 285 9.6k
Thomas Benfield Denmark 46 4.2k 1.3× 3.4k 1.2× 1.3k 0.6× 909 0.4× 894 0.5× 370 8.6k
Alexandra M. Levine United States 62 3.5k 1.1× 2.9k 1.0× 1.7k 0.8× 1.4k 0.7× 506 0.3× 253 11.6k
Louise Kuhn United States 55 5.4k 1.7× 5.2k 1.8× 2.8k 1.3× 931 0.4× 908 0.5× 321 11.5k
Kathryn Anastos United States 60 4.5k 1.4× 5.8k 2.1× 3.3k 1.5× 803 0.4× 705 0.4× 418 12.8k
Ruth M. Greenblatt United States 48 3.1k 1.0× 3.8k 1.4× 2.0k 0.9× 635 0.3× 674 0.4× 171 8.7k
Alfred J. Saah United States 57 6.4k 2.0× 5.3k 1.9× 4.8k 2.2× 2.7k 1.2× 456 0.2× 165 13.6k
Nigel Klein United Kingdom 67 3.5k 1.1× 2.2k 0.8× 711 0.3× 5.2k 2.4× 1.4k 0.7× 380 16.4k
Cathy W. Critchlow United States 57 5.7k 1.8× 1.5k 0.5× 743 0.3× 889 0.4× 2.4k 1.3× 146 10.9k
Peter A. Anton United States 43 1.4k 0.5× 1.8k 0.6× 1.9k 0.8× 1.3k 0.6× 698 0.4× 138 5.9k
Mardge H. Cohen United States 62 4.4k 1.4× 7.5k 2.7× 3.3k 1.4× 608 0.3× 929 0.5× 429 13.8k

Countries citing papers authored by Lars Østergaard

Since Specialization
Citations

This map shows the geographic impact of Lars Østergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Østergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Østergaard more than expected).

Fields of papers citing papers by Lars Østergaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Østergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Østergaard. The network helps show where Lars Østergaard may publish in the future.

Co-authorship network of co-authors of Lars Østergaard

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Østergaard. A scholar is included among the top collaborators of Lars Østergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Østergaard. Lars Østergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Østergaard, Lars, et al.. (2025). Combination therapy delays antimicrobial resistance after adaptive laboratory evolution of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 69(4). e0148324–e0148324. 1 indexed citations
2.
Jørgensen, Sofie E., Cagla Cömert, Berit Schiøttz‐Christensen, et al.. (2025). Genetic Landscape and Mitochondrial Metabolic Dysregulation in Patients Suffering From Severe Long COVID. Journal of Medical Virology. 97(3). e70275–e70275.
3.
Pedersen, Dennis, et al.. (2023). Nanobody‐mediated complement activation to kill HIV ‐infected cells. EMBO Molecular Medicine. 15(4). e16422–e16422. 10 indexed citations
4.
Gunst, Jesper Damsgaard, Ida Monrad, Andreas Holleufer, et al.. (2023). Redirector of Vaccine-induced Effector Responses (RoVER) for specific killing of cellular targets. EBioMedicine. 96. 104785–104785. 2 indexed citations
5.
Carmali, Sheiliza, Suzan H. M. Rooijakkers, Lars Østergaard, et al.. (2023). Antibody‐Drug Conjugates to Treat Bacterial Biofilms via Targeting and Extracellular Drug Release. Advanced Science. 10(23). e2301340–e2301340. 20 indexed citations
6.
Mogensen, Trine H., Jane Agergaard, Berit Schiøttz‐Christensen, et al.. (2022). High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial. The Lancet Regional Health - Europe. 24. 100539–100539. 29 indexed citations
7.
Vibholm, Line K., Ida Monrad, Rikke Olesen, et al.. (2021). SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity. EBioMedicine. 68. 103410–103410. 38 indexed citations
8.
9.
Stallknecht, Sandra Elkjær, et al.. (2018). Societal costs due to meningococcal disease: a national registry-based study. ClinicoEconomics and Outcomes Research. Volume 10. 563–572. 9 indexed citations
10.
Lausch, Karen Rokkedal, Mette Søgaard, Flemming Schønning Rosenvinge, et al.. (2018). Treatment of candidemia in a nationwide setting: increased survival with primary echinocandin treatment. Infection and Drug Resistance. Volume 11. 2449–2459. 9 indexed citations
11.
Rodkjær, Lotte Ørneborg, et al.. (2017). The Effect of a Mind–Body Intervention on Mental Health and Coping Self-Efficacy in HIV-Infected Individuals: A Feasibility Study. The Journal of Alternative and Complementary Medicine. 23(5). 326–330. 8 indexed citations
12.
Anderson, Jenny L., Rémi Fromentin, Giulio Maria Corbelli, Lars Østergaard, & Anna Laura Ross. (2014). Progress Towards an HIV Cure: Update from the 2014 International AIDS Society Symposium. AIDS Research and Human Retroviruses. 31(1). 36–44. 16 indexed citations
13.
Jakobsen, Martin R., Rasmus O. Bak, R. Berg, et al.. (2013). IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proceedings of the National Academy of Sciences. 110(48). E4571–80. 263 indexed citations
14.
Thorsen, Kasper, et al.. (2013). Leukocyte transcript alterations in West-African girls following a booster vaccination with diphtheria-tetanus-pertussis vaccine. Scandinavian Journal of Clinical and Laboratory Investigation. 73(4). 349–354. 2 indexed citations
15.
Storgaard, Merete, Martin Müller, Peter Sehr, et al.. (2013). Comparison of the Immunogenicity and Reactogenicity of Cervarix and Gardasil Human Papillomavirus Vaccines in HIV-Infected Adults: A Randomized, Double-Blind Clinical Trial. The Journal of Infectious Diseases. 209(8). 1165–1173. 64 indexed citations
16.
Østergaard, Lars, Elin Kolle, Jostein Steene‐Johannessen, Sigmund A. Anderssen, & Lars Bo Andersen. (2013). Cross sectional analysis of the association between mode of school transportation and physical fitness in children and adolescents. International Journal of Behavioral Nutrition and Physical Activity. 10(1). 91–91. 62 indexed citations
17.
Vibholm, Line K., Line S. Reinert, Ole S. Søgaard, et al.. (2012). Antiviral and Immunological Effects of Tenofovir Microbicide in Vaginal Herpes Simplex Virus 2 Infection. AIDS Research and Human Retroviruses. 28(11). 1404–1411. 13 indexed citations
18.
Leutscher, Peter Derek Christian, et al.. (2011). HIV late presenters in Denmark - need for increased diagnostic awareness among general practitioners. 8 indexed citations
19.
20.
Østergaard, Lars, et al.. (1994). Development of a nested polymerase chain reaction using time-resolved fluorometry for automated detection of Chlamydia trachomatis. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Benfield Breakdown of academic impact, for papers by Alexandra M. Levine Breakdown of academic impact, for papers by Louise Kuhn Breakdown of academic impact, for papers by Kathryn Anastos Breakdown of academic impact, for papers by Ruth M. Greenblatt Breakdown of academic impact, for papers by Alfred J. Saah Breakdown of academic impact, for papers by Nigel Klein Breakdown of academic impact, for papers by Cathy W. Critchlow Breakdown of academic impact, for papers by Peter A. Anton Breakdown of academic impact, for papers by Mardge H. Cohen
Rankless by CCL
2026